Suggestions
Michael Heltzen
Biology as Technology expert
Michael Heltzen is the Chief Executive Officer of Invizyne Technologies, a company specializing in enzyme-based biomanufacturing systems. His appointment was announced in May 2024, as Invizyne prepares for its public offering and aims to revolutionize the production of essential chemicals and molecules through innovative biomanufacturing techniques.14
Professional Background:: Before joining Invizyne, Heltzen held several significant positions:
- Executive Vice President for Strategy at Paragraf Ltd.
- Chief Executive Officer of Cardea Bio Inc.
- Chief Executive Officer and Chairman of Nanosens Innovations Inc., prior to its merger with Cardea Bio.1
Heltzen has over 20 years of experience in global commercial leadership and is recognized for his ability to launch and grow technology-driven companies. His focus has been on integrating biology with technology, particularly in the fields of bioinformatics and genomics.23
Philosophy and Vision:: Heltzen is passionate about the "Biology as Technology" movement, which merges biological sciences with digital computing, aiming to create innovative solutions in life sciences. He emphasizes building strong corporate cultures and empowering teams to drive innovation within the biotech industry.2
Education and Skills:: His background includes extensive experience in strategic development, business optimization, and international negotiations. Heltzen is fluent in English and Danish, with limited proficiency in German.2
Overall, Michael Heltzen's leadership at Invizyne is expected to leverage his extensive experience and vision to advance the company's mission in sustainable biomanufacturing.
